Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 31 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Keyword is Hepatitis B, Chronic  [Clear All Filters]
2018
Germanidis, G., Hytiroglou P., Vassiliadis T., & Speletas M. (2018).  Checkpoint modulation in chronic hepatitis B: From hypothesis to approval.. Hepatology. 67(3), 1175-1176.
Molyvdas, A., Georgopoulou U., Lazaridis N., Hytiroglou P., Dimitriadis A., Foka P., et al. (2018).  The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation.. Cytokine. 110, 389-396.
2016
Papatheodoridis, G., Thomas H. C., Golna C., Bernardi M., Carballo M., Cornberg M., et al. (2016).  Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.. J Viral Hepat. 23 Suppl 1, 1-12.
Cholongitas, E., Goulis I., Antoniadis N., Fouzas I., Imvrios G., Giakoustidis D., et al. (2016).  Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation.. Transpl Infect Dis. 18(5), 667-673.
2015
Cholongitas, E., Tziomalos K., & Pipili C. (2015).  Management of patients with hepatitis B in special populations.. World J Gastroenterol. 21(6), 1738-48.
Goulis, I., Karatapanis S., Akriviadis E., Deutsch M., Dalekos G. N., Raptopoulou-Gigi M., et al. (2015).  On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients.. Liver Int. 35(5), 1540-8.
Cholongitas, E., Vasiliadis T., Goulis I., Fouzas I., Antoniadis N., Papanikolaou V., et al. (2015).  Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease.. J Viral Hepat. 22(7), 574-80.
2014
Papatheodoridis, G., Goulis J., Manolakopoulos S., Margariti A., Exarchos X., Kokkonis G., et al. (2014).  Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy.. J Hepatol. 60(1), 62-8.
Kountouras, J., Patsiaoura K., Zavos C., Chatzopoulos D., Katsinelos P., Tantsi N., et al. (2014).  Letter: apoptosis and hepatic fibrosis in chronic hepatitis B.. Aliment Pharmacol Ther. 39(9), 996.
Cholongitas, E., Goulis I., Antoniadis N., Fouzas I., Imvrios G., Papanikolaou V., et al. (2014).  New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.. Transpl Int. 27(10), 1022-8.
Pipili, C., Cholongitas E., & Papatheodoridis G. (2014).  Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.. Aliment Pharmacol Ther. 39(1), 35-46.
2013
Tsoulfas, G., & Agorastou P. (2013).  Commentary on "Prophylaxis against HBV recurrence after liver transplantation for HBV-related endstage liver diseases with severe hypersplenism and splenomegaly: Role of splenectomy".. J Surg Res. 183(2), 548-9.
Pachiadakis, I., Choksi S., Ilonidis G., Akriviadis E., & Goulis I. (2013).  Letter to the editor concerning the paper: Boltjes A, Op den Brouw ML, Biesta PJ, et al. Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patients [Molecular Immunolog. Mol Immunol. 56(1-2), 129-30.
Marcellin, P., Gane E., Buti M., Afdhal N., Sievert W., Jacobson I. M., et al. (2013).  Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.. Lancet. 381(9865), 468-75.
Hatzakis, A., Van Damme P., Alcorn K., Gore C., Benazzouz M., Berkane S., et al. (2013).  The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.. J Viral Hepat. 20 Suppl 2, 1-20.
Pipili, C. L., Papatheodoridis G. V., & Cholongitas E. C. (2013).  Treatment of hepatitis B in patients with chronic kidney disease.. Kidney Int. 84(5), 880-5.
2012
Sarafidis, P. A., Georgianos P. I., Germanidis G., Giavroglou C., Nikolaidis P., Lasaridis A. N., et al. (2012).  Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis.. Am J Kidney Dis. 59(3), 434-8.
Rijckborst, V., Ferenci P., Akdogan M., Pinarbasi B., Borg M. J. ter, Simon K., et al. (2012).  Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders.. Eur J Gastroenterol Hepatol. 24(9), 1012-9.
2011
Liaw, Y-F., Raptopoulou-Gigi M., Cheinquer H., Sarin S. Kumar, Tanwandee T., Leung N., et al. (2011).  Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: a randomized, open-label study.. Hepatology. 54(1), 91-100.
Yoon, S-M., Gerasimidou D., Kuwahara R., Hytiroglou P., Yoo J. Eun, Park Y. Nyun, et al. (2011).  Epithelial cell adhesion molecule (EpCAM) marks hepatocytes newly derived from stem/progenitor cells in humans.. Hepatology. 53(3), 964-73.
Fylaktou, A., Asimina F., Papaventsis D., Dimitrios P., Daoudaki M., Maria D., et al. (2011).  Molecular epidemiology of chronic hepatitis B virus infection in Greece.. J Med Virol. 83(2), 245-52.
Pyrpasopoulou, A., Douma S., Vassiliadis T., Chatzimichailidou S., Triantafyllou A., & Aslanidis S. (2011).  Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis.. Rheumatol Int. 31(3), 403-4.
E Heathcote, J., Marcellin P., Buti M., Gane E., De Man R. A., Krastev Z., et al. (2011).  Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.. Gastroenterology. 140(1), 132-43.
Papatheodoridis, G. V., Manolakopoulos S., Touloumi G., Vourli G., Raptopoulou-Gigi M., Vafiadis-Zoumbouli I., et al. (2011).  Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece c. Gut. 60(8), 1109-16.
2010
Vassiliadis, T. G., Giouleme O., Koumerkeridis G., Koumaras H., Tziomalos K., Patsiaoura K., et al. (2010).  Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study.. J Gastroenterol Hepatol. 25(1), 54-60.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές